[Sponsored] LiveWorld’s white paper, Turning UGC into Insight: The Untapped Value in Pharma Conversations, identifies how moderated conversations become an insight pipeline, and what recurring questions, misinformation themes, and sentiment shifts actually signal. The post How User-Generated Content is Transforming Pharma Insights on the Patient Experience appeared first on MedCity News.
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” As a teenager, Rei Scott spent several weeks living out of a car with four family members and their dog. Each day, Scott worried about where they would spend the…
When minutes matter for a patient’s care, what is AI’s role in clinical practice? Elad Walach, co-founder and CEO of Aidoc — a company with a comprehensive AI health care platform that analyzes real-time images and flags time-sensitive findings — shares his perspective on AI’s transformative power in dodging diagnostic error, improving access to care,…
A new Business Group on Health survey found that while many employers currently cover GLP-1s for weight management, rising costs are prompting some to reconsider that coverage and adopt strategies to control spending. The post About 67% of Employers Cover GLP-1s for Weight Management; That Could Decline in 2027 appeared first on MedCity News.
By integrating AI with human oversight, Reimagine Care aims to enhance virtual oncology care
Beth Israel Lahey Health said modernizing its fax infrastructure during a major Epic EHR consolidation helped the health system slash fax failure rates from 34% to 4% and save $4 million. By adopting Retarus’ cloud-based platform, the health system simplified referrals and prescription processing, as well as reduced manual administrative work. The post How Beth…
Nineteen percent of adolescents experience moderate to severe anxiety and 2 million have a substance use disorder. This analysis covers the latest data on adolescent mental illness, suicide and drug overdose trends, and access to care.
Partner Therapeutics’ Bizengri is now FDA approved for treating advanced cases of cholangiocarcinoma driven by NRG1 gene fusions. Partner acquired U.S. rights to this bispecific antibody from Merus in 2024. The post A Cancer Driven by Ultra-Rare Mutation Gets Its First FDA-Approved Therapy appeared first on MedCity News.
From Charlie Bilello: Healthcare and Social Assistance have added nearly 1.8 million private-sector jobs in the US since the end of 2023 while all of other industries combined have lost 127,800 jobs.
By embracing better tools and smarter approaches, agencies can reduce the strain on their teams and give their patients the most seamless, high-quality care possible. The post Critical Care Documentation: Why It’s Different and How It Impacts Patient Care appeared first on MedCity News.